SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.

Amdal CD, Falk RS, Alanya A, Schlichting M, Roychoudhury S, Bhatnagar V, Wintner LM, Regnault A, Ingelgård A, Coens C, le Cessie S, Holzner B, Chang J, Taphoorn M, Cislo P, Giesinger JM, Cappelleri JC, Pawar V, Ten Seldam S, Papadopoulos EJ, Calvert MJ, Joseph KL, Bottomley A, Griebsch I, Arraras JI, Astrup GL, Basch E, Belančić A, Brundage M, Campbell A, Rerhou Rantell K, Cocks K, Cherny N, Eremenco S, Ferrer M, Fiero MH, Gerlinger C, Goetghebeur E, Grouven U, Lauer A, Aiyegbusi OL, Machingura A, Mizusawa J, Molenberghs G, Aa Petersen M, Reijneveld JC, Ringash J, Rumpold G, Rutherford C, Quinten C, Sail K, Sasseville M, Sauerbrei W, Schiel A, Smith AW, Snyder C, Velikova G, Wang XS, Bjordal K, Pe M, SISAQOL-IMI Consortium

Open source

DOI: 10.1016/s1470-2045(25)00520-0
Published: 2025 Dec
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-25-00520-0,
  title = {SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.},
  author = {Amdal CD and Falk RS and Alanya A and Schlichting M and Roychoudhury S and Bhatnagar V and Wintner LM and Regnault A and Ingelgård A and Coens C and le Cessie S and Holzner B and Chang J and Taphoorn M and Cislo P and Giesinger JM and Cappelleri JC and Pawar V and Ten Seldam S and Papadopoulos EJ and Calvert MJ and Joseph KL and Bottomley A and Griebsch I and Arraras JI and Astrup GL and Basch E and Belančić A and Brundage M and Campbell A and Rerhou Rantell K and Cocks K and Cherny N and Eremenco S and Ferrer M and Fiero MH and Gerlinger C and Goetghebeur E and Grouven U and Lauer A and Aiyegbusi OL and Machingura A and Mizusawa J and Molenberghs G and Aa Petersen M and Reijneveld JC and Ringash J and Rumpold G and Rutherford C and Quinten C and Sail K and Sasseville M and Sauerbrei W and Schiel A and Smith AW and Snyder C and Velikova G and Wang XS and Bjordal K and Pe M and SISAQOL-IMI Consortium},
  year = {2025},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(25)00520-0},
  url = {https://doi.org/10.1016/s1470-2045(25)00520-0}
}

RIS

TY  - JOUR
TI  - SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.
AU  - Amdal CD
AU  - Falk RS
AU  - Alanya A
AU  - Schlichting M
AU  - Roychoudhury S
AU  - Bhatnagar V
AU  - Wintner LM
AU  - Regnault A
AU  - Ingelgård A
AU  - Coens C
AU  - le Cessie S
AU  - Holzner B
AU  - Chang J
AU  - Taphoorn M
AU  - Cislo P
AU  - Giesinger JM
AU  - Cappelleri JC
AU  - Pawar V
AU  - Ten Seldam S
AU  - Papadopoulos EJ
AU  - Calvert MJ
AU  - Joseph KL
AU  - Bottomley A
AU  - Griebsch I
AU  - Arraras JI
AU  - Astrup GL
AU  - Basch E
AU  - Belančić A
AU  - Brundage M
AU  - Campbell A
AU  - Rerhou Rantell K
AU  - Cocks K
AU  - Cherny N
AU  - Eremenco S
AU  - Ferrer M
AU  - Fiero MH
AU  - Gerlinger C
AU  - Goetghebeur E
AU  - Grouven U
AU  - Lauer A
AU  - Aiyegbusi OL
AU  - Machingura A
AU  - Mizusawa J
AU  - Molenberghs G
AU  - Aa Petersen M
AU  - Reijneveld JC
AU  - Ringash J
AU  - Rumpold G
AU  - Rutherford C
AU  - Quinten C
AU  - Sail K
AU  - Sasseville M
AU  - Sauerbrei W
AU  - Schiel A
AU  - Smith AW
AU  - Snyder C
AU  - Velikova G
AU  - Wang XS
AU  - Bjordal K
AU  - Pe M
AU  - SISAQOL-IMI Consortium
PY  - 2025
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(25)00520-0
UR  - https://doi.org/10.1016/s1470-2045(25)00520-0
ER  -

APA

CD, A., RS, F., A, A., M, S., S, R., V, B., LM, W., A, R., A, I., C, C., S, L. C., B, H., J, C., M, T., P, C., JM, G., JC, C., V, P., S, T. S., EJ, P., MJ, C., KL, J., A, B., I, G., JI, A., GL, A., E, B., A, B., M, B., A, C., K, R. R., K, C., N, C., S, E., M, F., MH, F., C, G., E, G., U, G., A, L., OL, A., A, M., J, M., G, M., M, A. P., JC, R., J, R., G, R., C, R., C, Q., K, S., M, S., W, S., A, S., AW, S., C, S., G, V., XS, W., K, B., M, P., & Consortium, S. (2025). SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(25)00520-0

Source records

pubmed · retrieved 2026-09-26T12:57:37.809Z